王思为;蓝天;郑芳;雷美康;张峰;
WANG Si-wei;LAN Tian;ZHENG Fang;LEI Mei-kang;ZHANG Feng;Quzhou People′s Hospital;Quzhou Customs Technical Center;

• 1:衢州市人民医院
• 2:衢州海关技术中心

摘要(Abstract)：

研究衢枳壳提取物(QAF)对四氯化碳(CCl_4)诱导的肝纤维化小鼠肝脏炎症的影响及其机制。将60只C57BL/6雄性小鼠按照随机数字表法随机分为对照组(蒸馏水灌胃)、模型组(蒸馏水灌胃)、秋水仙碱组(Col,秋水仙碱2 mg·kg~(-1)·d~(-1)灌胃)、QAF低剂量组(QAF-L,QAF 100 mg·kg~(-1)·d~(-1)灌胃)和QAF高剂量组(QAF-H,QAF 300 mg·kg~(-1)·d~(-1)灌胃)。模型组和各给药组用1 mL·kg~(-1)CCl_4(CCl_4-橄榄油1∶4)腹腔注射,每周2次。给药和造模共6周。末次给药后16 h,处死小鼠,收集血清以及肝脏组织。检测血清谷丙转氨酶(alanine aminotransferase, ALT)和谷草转氨酶(aspartate aminotransferase, AST)水平,并观察小鼠肝功能情况;HE染色法观察各组小鼠肝组织病理学变化;F4/80免疫组化法观察各组小鼠肝脏炎症细胞浸润情况;采用RT-PCR法检测各组小鼠肝脏肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素(interleukin, IL)-18和IL-1β mRNA表达;采用Western blot法检测各组小鼠肝脏IκBα,p-IKKα/β,p-p65,NLRP3,caspase-1和cleaved caspase-1表达情况。结果显示,不同剂量QAF显著缓解肝损伤程度,并降低肝纤维化小鼠肝功能指标血清ALT和AST水平。免疫组化结果显示,QAF显著减少肝纤维化小鼠肝脏炎症细胞浸润。RT-PCR和Western blot结果显示,QAF显著降低肝纤维化小鼠肝组织TNF-α,IL-18和IL-1β基因表达,并抑制肝脏IκBα蛋白降解,以及p-IKKα/β,p-p65,NLRP3和cleaved caspase-1蛋白表达。综上所述,QAF具有改善CCl_4诱导的小鼠肝纤维化的作用,其机制可能与抑制NF-κB/NLRP3炎性体介导的炎症信号通路有关。
To study the effect and mechanism of extract of Quzhou Aurantii Fructus(QAF) on liver inflammation in CCl_4-induced liver fibrosis mice. Totally 60 C57 BL/6 male mice were randomly divided into control group(distilled water, oral), model group(distilled water, oral), colchicines group(Col, colchicines 2 mg·kg~(-1)·d~(-1), oral), low-dose QAF group(QAF-L, QAF 100 mg·kg~(-1)·d~(-1), oral) and high-dose QAF group(QAF-H, QAF 300 mg·kg~(-1)·d~(-1), oral) by random number table method. The model group and each administration group were injected with carbon tetrachloride(CCl_4) 1 mL·kg~(-1)(CCl_4-olive oil 1∶4), twice a week, totally 6 weeks. After the last administration, the mice were sacrificed, and serum and liver tissue were collected. Serum ALT and AST levels were measured in each group to observe the liver function of mice. The pathological changes and inflammatory cell infiltration in liver were observed by HE staining and F4/80 immunohistochemical staining. The mRNA expressions of TNF-α, IL-18 and IL-1β were detected by RT-PCR. The protein expressions of IκBα, p-IKKα/β, p-p65, NLRP3, caspase-1 and cleaved caspase-1 were analyzed by Western blot. The results showed that QAF significantly reduced serum ALT and AST levels, and alleviated the degree of liver damage.The results of immunohistochemistry showed that QAF significantly reduced liver inflammatory cell infiltration in liver fibrosis mice. The results of RT-PCR and Western blot showed that QAF significantly inhibited mRNA expressions of TNF-α, IL-18 and IL-1β in liver of fibrosis mice. QAF also suppressed the degradation of IκBα protein and reduced p-IKKα/β, p-p65, NLRP3 and cleaved caspase-1 protein expressions. In conclusion, QAF improves CCl_4-induced liver fibrosis in mice. The mechanism may be related to the inhibition of NF-κB/NLRP3 inflammasome-mediated inflammation signaling pathway.

关键词(KeyWords)： 衢枳壳;肝纤维化;炎症;NF-κB;NLRP3炎性体
Quzhou Aurantii Fructus;liver fibrosis;inflammation;NF-κB;NLRP3 inflammasome

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目(81903873);; 衢州市科技计划竞争性分配项目(2018K20,2019K34);; 浙江省医药卫生科技计划项目(2019PY089,2020PY087);; 浙江省中医药科技计划项目(2021ZB328)

作者(Author): 王思为;蓝天;郑芳;雷美康;张峰;
WANG Si-wei;LAN Tian;ZHENG Fang;LEI Mei-kang;ZHANG Feng;Quzhou People′s Hospital;Quzhou Customs Technical Center;

Email:

DOI: 10.19540/j.cnki.cjcmm.20201201.401

参考文献(References)：

• [1] 林远灿，骆海莺，刘慧芳，等.垂盆草总黄酮调控Smads通路抑制肝星状细胞活化的抗肝纤维化机制研究[J].中国中药杂志，2020,45(3):631.
• [2] 吕超，毛德文，石清兰，等.中药及其复方抗肝纤维化作用机制的研究进展[J].中国实验方剂学杂志，2020,26(4):242.
• [3] ALBILLOS A,NIETO M,UBEDA M,et al.The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis [J].Gut,2010,59(7):943.
• [4] ZHANG L,SCHUPPAN D.Traditional Chinese medicine (TCM) for fibrotic liver disease:hope and hype [J].J Hepatol,2014,61(1):166.
• [5] 冯茵怡，严炯艺，夏星，等.荔枝核总黄酮对CCl4诱导的大鼠肝纤维化的影响及作用机制和潜在Q-marker的预测[J].中国中药杂志，2020,45(23):5722.
• [6] 柯迎妹，江敏，周树波，等.兰坪虫草多糖组分分析及缓解小鼠肝纤维化研究[J].中国中药杂志，2020,45(21):5256.
• [7] 于收，孙延芬，王佳佳.参芪益肝汤对乙肝肝纤维化患者治疗前后肝功能及肝纤维化指标的影响及意义[J].世界中医药，2019,14(8):2121.
• [8] 吴菲，陈滨，李慧，等.中药复方治疗肝纤维化的研究进展[J].今日药学，2017,27(3):205.
• [9] 涂灿，何琴，周元园，等.基于代谢组学的大黄对正常和肝纤维化大鼠双向作用对比研究[J].药学学报，2018,53(7):1139.
• [10] 王笑笑，王思为，方月娟，等.衢枳壳不同组分体外降糖活性研究及4种黄酮组分含量分析[J].中国现代应用药学，2017,34(10):1418.
• [11] 徐霄，汪洋，王思为，等.衢枳壳黄酮组分抑制脂多糖诱导RAW264.7细胞炎症反应的作用机制研究[J].中国中医药科技，2019,26(4):529.
• [12] BAI Y F,WANG S W,WANG X X,et al.The flavonoid-rich Quzhou Fructus Aurantii extract modulates gut microbiota and prevents obesity in high-fat diet-fed mice [J].Nutr Diabetes,2019,9(1):30.
• [13] 郑慧，王思为，钟松阳，等.衢枳壳提取物改善2型糖尿病db/db模型小鼠肾脏氧化损伤的作用研究[J].浙江中西医结合杂志，2020,30(2):105.
• [14] WANG S W,SHENG H,BAI Y F,et al.Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice[J].Nutr Diabetes,2020,10(1):27.
• [15] PRADERE J P,KLUWE J,DE MINICIS S,et al.Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice [J].Hepatology,2013,58(4):1461.
• [16] GANDHI C R.Hepatic stellate cell activation and pro-fibrogenic signals [J].J Hepatol,2017,67 (5):1104.
• [17] SUN S C.The noncanonical NF-κB pathway[J].Immunol Rev,2012,246(1):125.
• [18] BROZ P,DIXIT V M.Inflammasomes:mechanism of assembly,regulation and signalling[J].Nat Rev Immunol,2016,16(7):407.
• [19] 黄苗，刘欣，董蕾，等.太白楤木对CCl4诱导肝纤维化大鼠的干预作用[J].中国中药杂志，2015,40(21):4251.
• [20] 付月月，朱兰平，张国梁，等.夏枯草硫酸多糖对CCl4致大鼠肝纤维化及TGF-β1诱导的大鼠肝星状细胞活化的影响[J].中国实验方剂学杂志，2018,24(14):147.
• [21] FRAISSE T,SAVEY L,HENTGEN V,et al.Non-amyloid liver involvement in familial Mediterranean fever:a systematic literature review [J].Liver Int,2020,40(6):1269.